Teladoc Health, Inc. (NYSE:TDOC) shares are volatile Monday, and the stock remains down by more than 11% over the last five days.
What To Know:
Teladoc Health released its third-quarter financial results last Tuesday and reported a loss of 35 cents per share and quarterly revenue of $660.238 billion.
The company also issued fourth-quarter guidance below estimates, with revenue anticipated to be between $658 million and $683 million, versus the $686.56 million estimate.
Last Wednesday, Oppenheimer analyst Michael Wiederhorn maintained Teladoc Health with an Outperform and lowered the price target from $35 to $26, and RBC Capital analyst Sean Dodge maintained the stock with an Outperform and lowered the price target from $35 to $30.
Teladoc Health shares have grabbed the attention of retail investors and short-sellers alike. TDOC is one of the top trending tickers on Stocktwits, and 18.73% of available TDOC shares are being sold short, according to data from Benzinga Pro.
Related News: What’s Going On With Coherus BioSciences Stock?
TDOC Price Action: According to Benzinga Pro, Teladoc Health shares are up 2.3% at $15.93 at the time of publication.
Image: Mohamed Hassan from Pixabay
